Financials in USD. Standardized financial statements.
A compact view of how InVitro International turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $878,937 | $811,290 | $792,628 | $853,511 | $1.00M | $1.10M | $1.05M | $846,335 | $855,615 | $884,245 |
| Revenue Growth? | +8.3% | +2.4% | -7.1% | -14.9% | -9.2% | +4.9% | +24.4% | -1.1% | -3.2% | 0.0% |
| Cost of Revenue? | $160,844 | $157,791 | $156,643 | $173,319 | $199,196 | $207,277 | $189,083 | $157,283 | $157,957 | $188,000 |
| Gross Profit? | $718,093 | $653,499 | $635,985 | $680,192 | $804,207 | $897,539 | $863,654 | $689,052 | $697,658 | $696,244 |
| Gross Margin? | +81.7% | +80.6% | +80.2% | +79.7% | +80.1% | +81.2% | +82.0% | +81.4% | +81.5% | +78.7% |
| Operating Expenses? | $631,075 | $585,198 | $661,324 | $796,960 | $830,993 | $866,245 | $803,070 | $647,319 | $659,741 | $588,539 |
| Operating Income? | $87,018 | $68,301 | -$25,339 | -$116,770 | -$26,790 | $31,290 | $60,580 | $41,730 | $37,920 | $107,700 |
| EBITDA? | $129,441 | $112,039 | $6,680 | $16,458 | $108,217 | $65,029 | $91,296 | $72,827 | $65,658 | $136,854 |
| Income Before Tax | $123,635 | $106,704 | $2,353 | $12,566 | $105,502 | $61,440 | $81,478 | $58,000 | $48,658 | $118,374 |
| Income Tax Expense | $1,655 | $0 | $800 | -$8,710 | $9,510 | $11,546 | $10,805 | $1,591 | $823 | -$4,529 |
| Net Income? | $121,980 | $106,704 | $1,553 | $21,276 | $95,992 | $49,894 | $70,673 | $56,409 | $47,835 | $122,903 |
| EPS? | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 |
| Diluted EPS? | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality